Back to Search

MICHAEL ANSTEAD, MD

MD

Pediatric Pulmonology Physician

NPI: 1245259035IndividualAccepts Medicare

Specialties, Licenses & Credentials

Pulmonary Disease Physician

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

27583(KY)
Pediatric Pulmonology PhysicianPrimary

Pediatrics — Pediatric Pulmonology

Code: 2080P0214X

27583(KY)

CMS Specialties

PrimaryPULMONARY DISEASE

Additional

CRITICAL CARE (INTENSIVISTS)INTERNAL MEDICINEPEDIATRIC MEDICINE

Education

UNIVERSITY OF KENTUCKY COLLEGE OF MEDICINE

Class of 1989

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa

NCT00431964COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (11)

Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.
PMID 22595153·Chest·2012
2-rct
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
PMID 20442386·JAMA·2010
4-observational
Effects of therapeutic doses of albuterol on beta2-adrenergic receptor density and metabolic changes.
PMID 11256555·J Asthma·2001
3-trial
Pediatric sleep disorders: new developments and evolving understanding.
PMID 11100960·Curr Opin Pulm Med·2000
6-review
Mucoid Inquilinus limosus in a young adult with cystic fibrosis.
PMID 19434691·Pediatr Pulmonol·2009
5-case
Insomnia and chronic heart failure.
PMID 18758945·Heart Fail Rev·2009
6-review
Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
PMID 18383117·Pediatr Pulmonol·2008
5-case
Azithromycin alters macrophage phenotype.
PMID 18230686·J Antimicrob Chemother·2008
4-observational
Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
PMID 17550598·Respir Res·2007
2-rct
Eosinophilic pneumonia induced by daptomycin.
PMID 17207858·J Infect·2007
5-case
Susceptibility of pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis.
PMID 11714203·Pharmacotherapy·2001
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
740 S LIMESTONE
LEXINGTON, KY 40536

Location

Practice Location

740 S LIMESTONE, LEXINGTON, KY
(859) 218-2509

Quick Facts

NPI
1245259035
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
37
Clinical Trials
1
Publications
11

Are you this provider?

Claim Your Profile